Real-time enrollment status for this heparin induced thrombocytopenia clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 8:49 AM UTC
| NCT Number | NCT05785819 |
| Recruiting Status | Terminated |
| Condition | Heparin Induced Thrombocytopenia |
| Phase | Clinical Trial |
| Target Enrollment | 60 participants |
| Active Locations | 14 sites in the US |
| Sponsor | Veralox Therapeutics |
| Last Updated on CT.gov | November 25, 2025 (Nov 25, 2025) |
As of March 2, 2026: Clinical trial NCT05785819 is currently terminated participants. This clinical trial study for heparin induced thrombocytopenia is not currently accepting new participants at 14 locations across the United States. The study is sponsored by Veralox Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05785819 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 14 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05785819 was last updated Nov 25, 2025 (November 25, 2025). HelloStudys verifies this status automatically.